Newsletter | April 14, 2025

04.14.25 -- Deploying Immunologic Viral Agents To Target Cancers

SPONSOR

Take a tour of Nanoform's best-in-class nanodevelopment capabilities, setting new standards in innovation. Their highly specialized team excels in creating unique nanoparticles for both small and large molecule APIs. With 14 development lines for small molecules and 5 for large molecules, Nanoform offers unmatched scalability and precision. Leveraging cutting-edge technology, they produce nanoformed materials as small as 10 nanometers. Learn more.

FEATURED EDITORIAL

Deploying Immunologic Viral Agents To Target Cancers

Sit and Deliver interview with Oncolytics Biotech CMO Thomas Heineman about deploying oncolytic viral agents for delivery of therapeutic payloads to lymph nodes and tumor sites.

Subcutaneous Self-Administration: 3 Market Drivers, 3 Delivery Challenges

Within this general trend toward self-administration, what are specific market drivers for subcutaneous delivery approaches? What delivery challenges will need to be addressed? 

INDUSTRY INSIGHTS

Managing Risks In Injectable Drug Delivery

Gain insights pertinent to efficient and effective drug development. Understand and execute a risked-based critical thinking approach related to injectable drug packaging and delivery.

Streamlining The Path To Market For Generic Drug-Device Combinations

Developing g-DDCPs is a complex and time-consuming process. By using a risk-based approach, manufacturers can streamline the development process and bring g-DDCPs to market more quickly.

'Smart Devices' vs. 'Smart Design' In User-Centric Autoinjector Design

Discover this Prefilled Primary Drug Container designed to overcome drug compatibility and functionality challenges found in traditional glass syringes and rubber plungers.

Subcutaneous Delivery Of Large-Volume Complex Biologics

Explore the key findings of a new wearable injector clinical trial, including its positive impact on patient experience and the broader benefits of wearable injectors for chronic disease management.

Spray Drying To Enable New Inhaled Drug Products

The formulation and spray drying process can help manufacture a stable, highly respirable powder and deliver products that require a high drug load, a biologic, or rapid onset therapeutic.

SPONSOR

Join experts in drug delivery innovation as they discuss advancements in long-standing devices, systems, and platforms. Covering technologies like autoinjectors, infusion pumps, OBS, combination products, and connected devices, this virtual panel discussion will explore technical and functional innovation needs, challenges, and successes. Register today for Drug Delivery Leader Live happening May 7th!

SOLUTIONS

Pessano Site Tour: Complex OSD CDMO Services Provider

EZ-fill Smart™ To Enhance Aseptic Fill-Finish For Injectables Production